For the second quarter in a row, animal diagnostics company IDEXX Laboratories (NASDAQ:IDXX) increased its revenue and earnings guidance. While other sectors of the economy are experiencing slower growth, IDEXX's core market -- companion animal diagnostics -- is growing nicely, and the company's 2015 shift to a direct sales model continues to generate impressive sales increases. Let's take a look at the details behind a good quarter of execution.
READ THE FULL EQUITY RESEARCH ARTICLE
Post a Comment